Related Experiment Video
Updated: Jul 24, 2026

08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Baylor multipurpose circulatory support system for short- to long-term use
M Shiono1, S Takatani, T Sasaki
1Department of Surgery, Baylor College of Medicine, Houston, Texas 77030.
Summary
A novel multipurpose circulatory support system functions as both temporary and permanent total artificial hearts (TAHs) and ventricular assist devices (VADs). This innovative system demonstrates promising survival rates without anticoagulation, applicable for diverse cardiac conditions.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Medical Technology
Background:
- Development of a versatile circulatory support system for both temporary and permanent use in treating end-stage heart disease.
- Concept derived from a totally implantable electromechanical, one-piece total artificial heart (TAH).
Purpose of the Study:
- To present a multipurpose circulatory support system adaptable as a total artificial heart (TAH) or ventricular assist device (VAD).
- To highlight the system's dual pneumatic (short-term) and electromechanical (long-term) actuation capabilities.
- To detail the shared components and unique features of the TAH and VAD versions.
Main Methods:
- Design and development of a compact pumping chamber with biolized gelatin, pusher-plate, Hexsyn rubber diaphragm, and bovine pericardial valves.
- Implementation of pneumatic drive for short-term use and electromechanical drive for long-term or permanent applications.
- Comparative analysis of VAD compactness against existing investigational devices.
Main Results:
- Both TAH and VAD versions achieved a 63 ml stroke volume.
- Electromechanical TAH demonstrated 1-week survival; electromechanical VAD achieved 2-week survival without anticoagulation.
- The VADs are notably compact compared to other investigational devices.
Conclusions:
- The developed multipurpose system offers a viable solution for various cardiac support needs, including post-cardiotomy, bridge to transplantation, and permanent support for end-stage heart disease.
- The system's adaptability and promising short-term survival data suggest significant potential in clinical applications.
- Further research and clinical trials are warranted to fully establish the long-term efficacy and safety of this innovative device.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

